Retinopathy of prematurity: incidence and risk factors

References

• Steinkuller PG, Du L, Gilbert C, Foster A, Collins ML, Coats D. Childhood blindness. J. AAPOS3, 26–32 (1999).
   PubMed Web of Science ®Google Scholar
• Kocur I, Resnikoff S. Visual impairment and blindness in Europe and their prevention. Br. J. Ophthalmol.86, 716–722 (2002).
   PubMed Web of Science ®Google Scholar
• Gilbert C, Foster A. Childhood blindness in the context of VISION 2020 – the right to sight. Bull. World Health Organ.79, 227–232 (2001).
   PubMed Web of Science ®Google Scholar
• Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. I. Preliminary report. Am. J. Ophthalmol.25, 203–204 (1942).
   Google Scholar
• Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia: a clinical approach. Med. J. Aust.2, 48–50 (1951).
   PubMedGoogle Scholar
• The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch. Ophthalmol.102, 1130–1134 (1984).
   PubMed Web of Science ®Google Scholar
• Muñoz B, West SK. Blindness and visual impairment in the Americas and the Caribbean. Br. J. Ophthalmol.86, 498–504 (2002).
   PubMed Web of Science ®Google Scholar
• Kocur I, Kuchynka P, Rodný S, Baráková D, Schwartz EC. Causes of severe visual impairment and blindness in children attending schools for the visually handicapped in the Czech Republic. Br. J. Ophthalmol.85, 1149–1152 (2001).
   PubMed Web of Science ®Google Scholar
• Gopal L, Sharma T, Shanmugam M et al. Surgery for stage 5 retinopathy of prematurity: the learning curve and evolving technique. Indian J. Ophthalmol.48, 101–106 (2000).
   PubMedGoogle Scholar
• Vohr BR, Wright LL, Dusick AM et al. Center differences and outcomes of extremely low birth weight infants. Pediatrics113, 781–789 (2004).
   PubMed Web of Science ®Google Scholar
• Lee SK, McMillan DD, Ohlsson A et al. Variations in practice and outcomes in the Canadian NICU Network: 1996–1997. Pediatrics106, 1070–1079 (2000).
   PubMed Web of Science ®Google Scholar
• Palmer EA, Flynn JT, Hardy RJ et al. Incidence and early course of retinopathy of prematurity. Ophthalmology98, 1628–1640 (1991).
   PubMed Web of Science ®Google Scholar
• Brown MS, Baron AE, France EK, Hamman RF. Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity. J. AAPOS10, 143–149 (2006).
   PubMed Web of Science ®Google Scholar
• Blair BM, O’Halloran HS, Pauly TH, Stevens JL. Decreased incidence of retinopathy of prematurity, 1995–1997. J. AAPOS5, 118–122 (2001).
   Google Scholar
• Mathew MR, Fern AI, Hill R. Retinopathy of prematurity: are we screening too many babies? Eye16, 538–542 (2002).
   PubMed Web of Science ®Google Scholar
• Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann. Acad. Med. Singapore34, 169–178 (2005).
   PubMed Web of Science ®Google Scholar
• Phan MH, Nguyen PN, Reynolds JD. Incidence and severity of retinopathy of prematurity in Vietnam, a developing middle-income country. J. Pediatr. Ophthalmol. Strabismus40, 208–212 (2003).
   PubMed Web of Science ®Google Scholar
• Larsson E, Carle-Petrelius B, Cernerud G, Ots L, Wallin A, Holmstrom G. Incidence of ROP in two consecutive Swedish population based studies. Br. J. Ophthalmol.86, 1122–1126 (2002).
   PubMed Web of Science ®Google Scholar
• Mayet I, Cockinos C. Retinopathy of prematurity in South Africans at a tertiary hospital: a prospective study. Eye20, 29–31 (2006).
   PubMed Web of Science ®Google Scholar
• Delport SD, Swanepoel JC, Odendaal PJ, Roux P. Incidence of retinopathy of prematurity in very-low-birth-weight infants born at Kalafong Hospital, Pretoria. S. Afr. Med. J.92, 986–990 (2002).
   PubMed Web of Science ®Google Scholar
• Yanovitch TL, Siatkowski RM, McCaffree M, Corff KE. Retinopathy of prematurity in infants with birth weight>or=1250 grams – incidence, severity, and screening guideline cost-analysis. J. AAPOS10, 128–134 (2006).
   PubMed Web of Science ®Google Scholar
• Mutlu FM, Altinsoy HI, Mumcuoglu T et al. Frequency and risk factor analysis for retinopathy of prematurity: a multivariate statistical analysis. J. Pediatr. Ophthalmol. Strabismus (In press).
   Google Scholar
• Early Treatment for Retinopathy of Prematurity Cooperative Group. Results of the Early Treatment for Retinopathy of Prematurity Randomized Trial: revised indications for the treatment of retinopathy of prematurity. Arch. Ophthalmol.121, 1684–1696 (2003).
   PubMed Web of Science ®Google Scholar
• Early Treatment for Retinopathy of Prematurity Cooperative Group. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics116, 15–23 (2005).
   PubMed Web of Science ®Google Scholar
• Quinn GE. What do we do about ROP in larger birth weight babies? Br. J. Ophthalmol.86, 1072–1073 (2002).
   PubMed Web of Science ®Google Scholar
• Reynolds JD, Dobson V, Quinn GE et al. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch. Ophthalmol.120, 1470–1476 (2003).
   Google Scholar
• Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics117, 572–576 (2006).
   PubMed Web of Science ®Google Scholar
• Jalali S, Matalia J, Hussain A, Anand R. Modification of screening criteria for retinopathy of prematurity in India and other middle-income countries. Am. J. Ophthalmol.141, 966–968 (2006).
   PubMed Web of Science ®Google Scholar
• Chow LC, Wright KW, Sola A; CSMC Oxygen Administration Study Group. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics111, 339–345 (2003).
   PubMed Web of Science ®Google Scholar
• Rowlands E, Ionides AC, Chinn S, Mackinnon H, Davey CC. Reduced incidence of retinopathy of prematurity. Br. J. Ophthalmol.85, 933–935 (2001).
   PubMed Web of Science ®Google Scholar
• Allegaert K, de Coen K, Devlieger H; EpiBel Study Group. Threshold retinopathy at threshold of viability: the EpiBel study. Br. J. Ophthalmol.88, 239–242 (2004).
   PubMed Web of Science ®Google Scholar
• Fielder AR, Posner EJ. Neonatal ophthalmology. In: Roberton’s Textbook of Neonatology. Rennie JM (Ed.). Elsevier Churchill Livingstone, London, UK 835–850 (2005).
   Google Scholar
• Schaffer DB, Palmer EA, Plotsky DF et al. Prognostic factors in the natural course of retinopathy of prematurity. THA Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology100, 230–237 (1993).
   PubMed Web of Science ®Google Scholar
• Akkoyun I, Oto S, Yilmaz G et al. Risk factors in the development of mild and severe retinopathy of prematurity. J. AAPOS10, 449–453 (2006).
   PubMed Web of Science ®Google Scholar
• Vanderveen DK, Mansfield TA, Eichenwald EC. Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity. J. AAPOS10, 445–448 (2006).
   PubMed Web of Science ®Google Scholar
• York JR, Landers S, Kirby RS, Arbogast PG, Penn JS. Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. J. Perinatol.24, 82–87 (2004).
   PubMedGoogle Scholar
• McColm JR, Geisen P, Hartnett ME. VEGF isoforms and their expression after a single episode of hypoxia or repeated oxygen fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. Mol. Vis.10, 512–520 (2004).
   PubMed Web of Science ®Google Scholar
• The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for Pretheshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics105, 295–310 (2000).
   PubMed Web of Science ®Google Scholar
• Lubetzky R, Stolovitch C, Dollberg S, Mimouni FB, Salomon M, Mandel D. Nucleated red blood cells in preterm infants with retinopathy of prematurity. Pediatrics116, e619–e622 (2005).
   PubMed Web of Science ®Google Scholar
• Shohat M, Reisner SH, Krikler R, Nissenkorn I, Yassur Y, Ben-Sira I. Retinopathy of prematurity: incidence and risk factors. Pediatrics72, 159–163 (1983).
   PubMed Web of Science ®Google Scholar
• Brown DR, Milley JR, Ripepi UJ et al. Retinopathy of prematurity. Risk factors in a five-year cohort of critically ill premature neonates. Am. J. Dis. Child.141, 154–160 (1987).
   PubMedGoogle Scholar
• Smith LE. Pathogenesis of retinopathy of prematurity. Growth Horm. IGF Res.14, 140–144 (2004).
   PubMed Web of Science ®Google Scholar
• Smith LE. IGF-I and retinopathy of prematurity in the preterm infant. Biol. Neonate88, 237–244 (2005).
   PubMedGoogle Scholar
• Hellström A, Engström E, Hard AL et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics112, 1016–1020 (2003).
   PubMed Web of Science ®Google Scholar
• Ozkan H, Duman N, Kumral A et al. Inhibition of vascular endothelial growth factor-induced retinal neovascularization by retinoic acid in experimental retinopathy of prematurity. Physiol. Res.55, 267–275 (2006).
   PubMed Web of Science ®Google Scholar
• Bizzarro MJ, Hussain N, Jonsson B et al. Genetic susceptibility to retinopathy of prematurity. Pediatrics118, 1858–1863 (2006).
   PubMed Web of Science ®Google Scholar
• Vannay A, Dunai G, Banyasz I et al. Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity. Pediatr. Res.57, 396–398 (2005).
   PubMed Web of Science ®Google Scholar
• Cooke WI, Drury JA, Mountford R, Clark D. Genetic polymorphisms and retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci.45, 1712–1715 (2004).
   PubMed Web of Science ®Google Scholar
• Yang MB, Donovan EF, Wagge JR. Race, gender, and clinical risk index for babies (CRIB) score as predictors of severe retinopathy of prematurity. J. AAPOS10, 253–261 (2006).
   PubMed Web of Science ®Google Scholar
• Tadesse M, Dhanireddy R, Mittal M, Higgins RD. Race, candida sepsis, and retinopathy of prematurity. Biol. Neonate81, 86–90 (2002).
   PubMedGoogle Scholar
• Hutcheson KA, Paluru PC, Bernstein SL et al. Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. Mol. Vis.14, 501–508 (2005).
   Google Scholar
• Hiraoka M, Berinstein DM, Trese MT, Shastry BS. Insertion and deletion mutations in the dinucleotide repeat region of the Norrie disease gene in patients with advanced retinopathy of prematurity. J. Hum. Genet.46, 178–181 (2001).
   PubMed Web of Science ®Google Scholar
• Downey LM, Keen TJ, Roberts E, Mansfield DC, Bamashmus M, Inglehearn CF. A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12–13. Am. J. Hum. Genet.68, 778–781 (2001).
   PubMed Web of Science ®Google Scholar
• Console V, Gagliardi L, De Giorgi A, De Ponti E. Retinopathy of prematurity and antenatal corticosteroids. The Italian ROP Study Group. Acta Biomed. Ateneo. Parmense68, 75–79 (1997).
   PubMedGoogle Scholar
• Haroon Parupia MF, Dhanireddy R. Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants. J. Perinatol.21, 242–247 (2001).
   PubMedGoogle Scholar
• Schmidt B, Davis P, Moddemann D et al. Long-term effects of indomethacin prophylaxis in extremely low-birth-weight infants. N. Engl. J. Med.344, 1966–1972 (2001).
   PubMed Web of Science ®Google Scholar
• Sharma J, Barr SM, Geng Y, Yun Y, Higgins RD. Ibuprofen improves oxygen-induced retinopathy in a mouse model. Curr. Eye Res.27, 309–314 (2003).
   PubMed Web of Science ®Google Scholar
• Van Overmeire B, Allegaert K, Casaer A et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet364, 1945–1949 (2004).
   PubMed Web of Science ®Google Scholar
• Hosono S, Ohno T, Kimoto T et al. No clinical correlation between bilirubin levels and severity of retinopathy of prematurity. J. Pediatr. Ophthalmol. Strabismus39, 151–156 (2002).
   PubMed Web of Science ®Google Scholar
• Milner JD, Aly HZ, Ward LB, El-Mohandes A. Does elevated peak bilirubin protect from retinopathy of prematurity in very low birthweight infants. J. Perinatol.23, 208–211 (2003).
   PubMedGoogle Scholar
• Reynolds JD, Hardy RJ, Kennedy KA, Spencer R, van Heuven WA, Fielder AR. Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. N. Engl. J. Med.338, 1572–1576 (1998).
   PubMed Web of Science ®Google Scholar
• Phelps DL, Watts JL. Early light reduction for preventing retinopathy of prematurity in very low birth weight infants. Cochrane Database Syst. Rev.1, CD0000122 (2001).
   Google Scholar
• Inder TE, Graham PJ, Winterbourn CC, Austin NC, Darlow BA. Plasma vitamin A levels in the very low birth weight infant: relationship to respiratory outcome. Early Hum. Dev.52, 155–168 (1998).
   PubMed Web of Science ®Google Scholar
• Shenai JP, Kennedy KA, Chytil F, Stahlman MT. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J. Pediatr.111, 269–277 (1987).
   PubMed Web of Science ®Google Scholar
• Ambalavanan N, Wu TJ, Tyson JE, Kennedy KA, Roane C, Carlo WA. A comparison of three vitamin A dosing regimes in extremely-low-birth-weight infants. J. Pediatr.142, 656–661 (2003).
   PubMed Web of Science ®Google Scholar
• Darlow BA, Graham PJ. Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database Syst. Rev.4, CD000501 (2002).
   Google Scholar
• Raju TK, Langenberg P, Bhutani V et al. Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials. J. Pediatr.131, 844–850 (1997).
   PubMed Web of Science ®Google Scholar
• Law MR, Wijewardene K, Wald NJ. Is routine vitamin E administration justified in very low-birthweight infants? Dev. Med. Child Neurol.32, 442–450 (1990).
   PubMed Web of Science ®Google Scholar
• Friedman CA, McVey J, Borne MJ et al. Relationship between serum inositol concentration and development of retinopathy of prematurity: a prospective study. J. Pediatr. Ophthalmol. Strabismus37, 79–86 (2000).
   PubMed Web of Science ®Google Scholar
• Englert JA, Saunders RA, Purohit D, Hulsey TC, Ebeling M. The effect of anemia on retinopathy of prematurity in extremely low birth weight infants. J. Perinatol.21, 21–26 (2001).
   PubMedGoogle Scholar
• Pennefather PM, Tin W. Ocular abnormalities associated with cerebral palsy after preterm birth. Eye14, 78–81 (2000).
   PubMed Web of Science ®Google Scholar
• Wallace DK, Kylstra JA, Phillips SJ, Hall JG. Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity. J. AAPOS4, 343–347 (2000).
   PubMed Web of Science ®Google Scholar
• Karlowicz MG, Giannone PJ, Pestian J, Morrow AL, Shults J. Does candidemia predict threshold retinopathy of prematurity in extremely low birth weight (</=1000 g) neonates? Pediatrics105, 1036–1040 (2000).
   PubMed Web of Science ®Google Scholar
• Seiberth V, Linderkamp O. Risk factors in retinopathy of prematurity. A multivariate statistical analysis. Ophthalmologica214, 131–135 (2000).
   PubMed Web of Science ®Google Scholar
• Watts P, Adams GG. In vitro fertilisation and stage 3 retinopathy of prematurity. Eye14, 330–333 (2000).
   PubMed Web of Science ®Google Scholar